Skip to content

A randomized controlled study of Shenfuhuang Compound in the treatment of sepsis

A randomized controlled study on the treatment of sepsis with Shenfuhuang Compound

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088940
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-09-30
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Experimental Group:On the basis of routine treatment of sepsis, Shenfuhuang decoction granules were added, 1 bag once, twice a day. It was dissolved in 20ml of water and administered orally or nasogas

Sponsors

Beijing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) consistent with the diagnosis of sepsis; (2) age =18 years old; (3) Voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) pregnant or preparing for pregnancy; (2) patients with severe mental disorders; (3) the expected survival time of patients is less than 28 days due to underlying diseases, such as poor control of malignant tumors, cardiac arrest within the past 30 days, etc.; (4) survival status of plants; (5) confirmed or highly suspected acute infectious diseases, such as active viral hepatitis, active tuberculosis, etc.; (6) allergy to the active ingredients of the test drug or its excipients; (7) participated in clinical intervention trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
28-day mortality;

Secondary

MeasureTime frame
SOFA score;Length of ICU stay;DIC score;

Countries

China

Contacts

Public ContactXuerui Wang

Beijing Hospital of Traditional Chinese Medicine

roxiewang@aliyun.com+86 139 1143 6833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026